Screener
Microbot Medical MBOT Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Microbot Medical’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001493152-26-037009
| Line item | 2026 / For the Three Months Ended June 30, | 2025 / For the Three Months Ended June 30, | 2026 / For the Six Months Ended June 30, | 2025 / For the Six Months Ended June 30, |
|---|---|---|---|---|
| Research and development, net | (1,861) | (2,111) | (3,154) | (3,570) |
| Sales, general and administrative | (3,684) | (1,612) | (6,713) | (3,174) |
| Operating loss | (6,188) | (3,723) | (10,508) | (6,744) |
| Other income (see Note 3F) | - | - | - | 316 |
| Financing income, net | 561 | 223 | 1,210 | 327 |
| Net loss | $(5,627) | $(3,500) | $(9,298) | $(6,101) |
| Basic and diluted net loss per share | $(0.08) | $(0.10) | $(0.14) | $(0.18) |
| Basic and diluted weighted average common shares outstanding | 67,163,613 | 36,488,014 | 67,160,844 | 33,801,734 |
Document
FAQ
- What is Microbot Medical's net income?
- Microbot Medical (MBOT) reported net income of -$5.63M in Q2 2026.
- How has Microbot Medical's net income changed year-over-year?
- Microbot Medical's net income decreased by 60.8% year-over-year, from -$3.5M to -$5.63M.
- What is the long-term trend for Microbot Medical's net income?
- Over 4 years (2021 to 2025), Microbot Medical's net income has grown at a 3.8% compound annual growth rate (CAGR), from -$11.31M to -$13.14M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Microbot Medical's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude